Paul Song's most recent trade in NKGen Biotech Inc was a trade of 41,699,449 Warrant done . Disclosure was reported to the exchange on May 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NKGen Biotech Inc | Paul Y. Song | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 05 May 2025 | 41,699,449 | 41,699,449 | - | - | Warrant | |
| NKGen Biotech Inc | Paul Y. Song | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.13 per share. | 05 May 2025 | 20,849,725 | 21,020,846 | - | 0.1 | 2,650,000 | Common Stock |
| NKGen Biotech Inc | Paul Y. Song | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2024 | 2,000,000 | 2,000,000 | - | - | Stock Option (right to buy) | |
| NKGen Biotech Inc | Paul Song | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 1,260,000 | 1,260,000 | - | - | Stock Option (right to buy) |